SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to fight tough head and neck cancers
Disease control OngoingThis study is testing whether a combination of an immunotherapy drug (cemiplimab) and two low-dose chemotherapy drugs works better for treating head and neck cancer that has returned or spread. The goal is to see if this combination helps shrink tumors and control the disease for…
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Virus + drug combo tested for Tough-to-Treat skin cancers
Disease control OngoingThis study is testing a two-part treatment for patients with advanced skin cancers or rare lymphomas that have not responded to other therapies. First, a modified virus is injected directly into tumors to help the immune system recognize cancer. Then, an immunotherapy drug is giv…
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC